CardioAssure utilizes a zero trust architecture to enhance the remote monitoring of cardiac implantable devices, ensuring secure data transmission and access control. This approach addresses vulnerabilities in patient data security and device integrity, providing healthcare providers with reliable and protected monitoring solutions.
Funding
Funding not disclosed
Founders
Product
Problem
Remote monitoring of cardiac implantable devices faces vulnerabilities in data security and device integrity, potentially compromising patient data and the reliability of monitoring solutions. Traditional security measures may not adequately protect against unauthorized access and data breaches.
Solution
CardioAssure employs a zero-trust architecture to modernize and enhance the security of remote monitoring for cardiac implantable devices. This approach ensures secure data transmission and stringent access control, mitigating risks associated with patient data security and device integrity. By implementing zero trust principles, CardioAssure provides healthcare providers with a more reliable and protected monitoring solution, reducing the potential for unauthorized access and data breaches. The platform aims to provide a secure environment for managing sensitive patient information and device performance data.
Target Audience
Healthcare providers involved in the remote monitoring of patients with cardiac implantable devices.
Features
- Zero trust architecture for enhanced security
- Secure data transmission protocols
- Stringent access control mechanisms